Similar articles for PMID: 16115934

Year	Number of Results
1948	1
1950	1
1951	1
1952	1
1959	2
1979	1
1983	1
1987	1
1988	1
1989	4
1990	4
1991	8
1992	2
1993	5
1994	8
1995	10
1996	12
1997	13
1998	13
1999	16
2000	13
2001	8
2002	12
2003	20
2004	9
2005	25
2006	14
2007	7
2008	5
2009	9
2010	5
2011	8
2012	5
2013	6
2014	5
2015	5
2016	7
2017	6
2018	12
2019	8
2020	5
2021	5
2023	1
2024	0

1

High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.

Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. Richman CM, et al. Clin Cancer Res. 2005 Aug 15;11(16):5920-7. doi: 10.1158/1078-0432.CCR-05-0211. Clin Cancer Res. 2005. PMID: 16115934 Clinical Trial.

2

Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.

DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL. DeNardo SJ, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7187s-7194s. doi: 10.1158/1078-0432.CCR-1004-0013. Clin Cancer Res. 2005. PMID: 16203820

3

Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?

Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. Miers L, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7158s-7163s. doi: 10.1158/1078-0432.CCR-1004-0012. Clin Cancer Res. 2005. PMID: 16203816

4

Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.

DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. DeNardo SJ, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3938S-44S. Clin Cancer Res. 2003. PMID: 14506192

5

Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.

Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. Richman CM, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3243s-3248s. Clin Cancer Res. 1999. PMID: 10541370

6

Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients.

DeNardo GL, DeNardo SJ. DeNardo GL, et al. Cancer Biother Radiopharm. 2004 Feb;19(1):85-92. doi: 10.1089/108497804773391720. Cancer Biother Radiopharm. 2004. PMID: 15068616

7

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.

Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. Denardo SJ, et al. Anticancer Res. 1997 May-Jun;17(3B):1735-44. Anticancer Res. 1997. PMID: 9179227 Clinical Trial.

8

Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.

Deb N, Goris M, Trisler K, Fowler S, Saal J, Ning S, Becker M, Marquez C, Knox S. Deb N, et al. Clin Cancer Res. 1996 Aug;2(8):1289-97. Clin Cancer Res. 1996. PMID: 9816299 Clinical Trial.

9

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Wong JY, Shibata S, Williams LE, Kwok CS, Liu A, Chu DZ, Yamauchi DM, Wilczynski S, Ikle DN, Wu AM, Yazaki PJ, Shively JE, Doroshow JH, Raubitschek AA. Wong JY, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52. Clin Cancer Res. 2003. PMID: 14676105 Review.

10

Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.

O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. O'Donnell RT, et al. Clin Cancer Res. 2001 Jun;7(6):1561-8. Clin Cancer Res. 2001. PMID: 11410491 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

290 results

Results by year